We are live on
!
Find out more
RMA
Roffman Miller Associates Portfolio holdings
AUM
$1.91B
1-Year Est. Return
28.29%
This Fund
S&P 500
This Quarter
Est. Return
+7.1%
1 Year Est. Return
+28.29%
3 Year Est. Return
+68.87%
5 Year Est. Return
+84.92%
10 Year Est. Return
+298.67%
AUM
$1.64B
AUM Growth
+$120M
(+7.9%)
Cap. Flow
+$24.5M
Cap. Flow
% of AUM
1.49%
Top 10 Holdings %
Top 10 Hldgs %
39.75%
Holding
80
New
5
Increased
46
Reduced
28
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$15M |
| 2 |
ASML
ASML
|
+$5.16M |
| 3 |
Amazon
AMZN
|
+$4.05M |
| 4 |
Apple
AAPL
|
+$2.54M |
| 5 |
Costco
COST
|
+$2.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$15.6M |
| 2 |
FedEx
FDX
|
+$5.84M |
| 3 |
Merck
MRK
|
+$2.96M |
| 4 |
Boeing
BA
|
+$1.08M |
| 5 |
Albemarle
ALB
|
+$925K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.65% |
| 2 | Financials | 16.35% |
| 3 | Industrials | 12.3% |
| 4 | Consumer Discretionary | 10.4% |
| 5 | Healthcare | 10.33% |
Similar funds
RIL
MC
BOH
6CM
QOP
IAN
RCAG
FTCM
Roffman Miller Associates's Q3 2024 Portfolio in Review
As of Q3 2024, Roffman Miller Associates held 80 positions worth $1.64B, up 7.9% from $1.52B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Roffman Miller Associates's Q3 2024 filing shows 5 new, 46 increased and 28 reduced positions. The largest sale was Medtronic, an estimated $15.6M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Financials and Industrials.
- Roffman Miller Associates added most to Cigna in Q3 2024, an estimated $15M increase.
- Roffman Miller Associates's biggest Q3 2024 reduction was Medtronic, cutting an estimated $15.6M.
- Roffman Miller Associates's ten largest holdings make up 40% of its $1.64B portfolio in Q3 2024.
- Roffman Miller Associates opened 5 new positions and closed 0 in Q3 2024.
- Roffman Miller Associates's portfolio value rose 7.9% quarter-over-quarter to $1.64B.
Based on Roffman Miller Associates's 13F filing for Q3 2024, filed 15 Nov 2024.